B. Han

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

W. Gillanders, Jian Ye, R. Fields, 2017, Gut.

Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma

S. Gerber, Jian Ye, D. Linehan, 2020, Immunological investigations.

Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

S. Gerber, Jian Ye, C. Johnston, 2022, Journal for ImmunoTherapy of Cancer.

Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast

L. Esserman, J. Gray, F. Baehner, 2016, Breast Cancer Research and Treatment.

Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer

S. Gerber, Jian Ye, C. Johnston, 2019, Cancer Immunology Research.

Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment

Jian Ye, Scott A. Gerber, Nejat K. Egilmez, 2019, Cell reports.

Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model

A. Reuben, S. Gerber, D. Linehan, 2020, bioRxiv.